Canevari L, Clark J B, Bates T E
Department of Neurochemistry, Institute of Neurology, London, UK.
FEBS Lett. 1999 Aug 20;457(1):131-4. doi: 10.1016/s0014-5793(99)01028-5.
Defects in mitochondrial oxidative metabolism, in particular decreased activity of cytochrome c oxidase, have been demonstrated in Alzheimer's disease, and after the expression of the amyloid precursor protein (APP) in cultured cells, suggesting that mitochondria might be involved in beta-amyloid toxicity. Recent evidence suggests that the proteolysis of APP to generate beta-amyloid is at least in part intracellular, preceding the deposition of extracellular fibrils. We have therefore investigated the effect of incubation of isolated rat brain mitochondria with the beta-amyloid fragment 25-35 (100 microM) on the activities of the mitochondrial respiratory chain complexes I, II-III, IV (cytochrome c oxidase) and citrate synthase. The peptide caused a rapid, dose-dependent decrease in the activity of complex IV, white it had no effect on the activities on any of the other enzymes tested. The reverse sequence peptide (35-25) had no effect on any of the activities measured. We conclude that inhibition of mitochondrial complex IV might be a contributing factor to the pathogenesis of Alzheimer's disease.
线粒体氧化代谢缺陷,尤其是细胞色素c氧化酶活性降低,已在阿尔茨海默病中得到证实,并且在培养细胞中表达淀粉样前体蛋白(APP)后也得到证实,这表明线粒体可能参与了β-淀粉样蛋白的毒性作用。最近的证据表明,APP蛋白水解产生β-淀粉样蛋白至少部分是在细胞内进行的,先于细胞外纤维的沉积。因此,我们研究了用β-淀粉样蛋白片段25-35(100微摩尔)孵育分离的大鼠脑线粒体对线粒体呼吸链复合物I、II-III、IV(细胞色素c氧化酶)和柠檬酸合酶活性的影响。该肽导致复合物IV的活性迅速、剂量依赖性降低,而对所测试的任何其他酶的活性均无影响。反向序列肽(35-25)对所测量的任何活性均无影响。我们得出结论,线粒体复合物IV的抑制可能是阿尔茨海默病发病机制的一个促成因素。